Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Shilpa Medicare informs about disclosure

24 Aug 2019

Shilpa Medicare has informed about the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Innani. 

The above information is a part of company’s filings submitted to BSE.

Related Shilpa Medicare Ltd. Links:

Shilpa Medicare Share Price

645.00 13.05 (2.07%) Aug 02, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 774.45
Dr. Reddy's Lab 4701.80
Lupin 1123.95
Cadila Healthcare 591.70
Aurobindo Pharma 918.00
View more..
Sensex vs Shilpa Medicare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback